New evidence from a large population-based cohort analysis indicates an increased risk of both attempted and completed ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels.

Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.

Living with chronic, persistent pain is a fact of life for 3 out of 10 people in the U.S. What people would give up to reduce ...

Unlike traditional migraines, you may not always have a headache. Along with dizziness, you may have symptoms such as loss of balance and nausea, with or without head pain. “Vestibular ...

Take extra care to avoid known triggers and follow these tips to help make your trip (hopefully) pain-free. Avoid the stress that can lead to migraine pain by organizing your itinerary and travel ...